BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis 2019;68:e1-e47. [PMID: 30566567 DOI: 10.1093/cid/ciy866] [Cited by in Crossref: 166] [Cited by in F6Publishing: 155] [Article Influence: 83.0] [Reference Citation Analysis]
Number Citing Articles
1 Poelman R, der Meer JV, der Spek CV, Riezebos-Brilman A, Knoester M, Leer-Buter CV, Friedrich AW, Niesters HG. Improved diagnostic policy for respiratory tract infections essential for patient management in the emergency department. Future Microbiol 2020;15:623-32. [PMID: 32490688 DOI: 10.2217/fmb-2019-0119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lim JJ, Dar S, Venter D, Horcajada JP, Kulkarni P, Nguyen A, Mcbride JM, Deng R, Galanter J, Chu T, Newton EM, Tavel JA, Peck MC. A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection. Open Forum Infectious Diseases 2022;9:ofab630. [DOI: 10.1093/ofid/ofab630] [Reference Citation Analysis]
3 Abraham GM, Morton JB, Saravolatz LD. Baloxavir: A Novel Antiviral Agent in the Treatment of Influenza. Clinical Infectious Diseases 2020;71:1790-4. [DOI: 10.1093/cid/ciaa107] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
4 Uyeki TM, Wentworth DE, Jernigan DB. Influenza Activity in the US During the 2020-2021 Season. JAMA 2021;325:2247. [DOI: 10.1001/jama.2021.6125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Cillóniz C, Pericàs JM, Rojas JR, Torres A. Severe Infections Due to Respiratory Viruses. Semin Respir Crit Care Med 2022;43:60-74. [PMID: 35172359 DOI: 10.1055/s-0041-1740982] [Reference Citation Analysis]
6 Channick CL, Garrison G, Huie TJ, Narewski E, Caplan-Shaw C, Cho J, Rafeq S, Alalawi R, Alashram R, Bailey KL, Carmona EM, Habib N, Kapolka R, Krishnan A, Lammi MR, Peck T, Pennington KM, Rali P, Small BL, Swenson C, Witkin A, Hayes MM. ATS Core Curriculum 2020. Adult Pulmonary Medicine. ATS Sch 2020;1:416-35. [PMID: 33870311 DOI: 10.34197/ats-scholar.2020-0016RE] [Reference Citation Analysis]
7 Schrodt CA, Malenfant JH, Hunter JC, Slifka KJ, Campbell A, Stone N, Whitehouse ER, Wittry B, Christensen B, Barnes JR, Brammer L, Hemarajata P, Green NM, Civen R, Gounder PP, Rao AK. Investigation of a Suspect Severe Acute Respiratory Syndrome Coronavirus-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide. Clin Infect Dis 2021;73:S77-80. [PMID: 33956136 DOI: 10.1093/cid/ciab372] [Reference Citation Analysis]
8 Salamanca A, Almodóvar P, Jarama I, González-Hedström D, Prodanov M, Inarejos-García AM. Anti-influenza virus activity of the elenolic acid rich olive leaf (Olea europaea L.) extract Isenolic®. Antivir Chem Chemother 2021;29:20402066211063391. [PMID: 34839747 DOI: 10.1177/20402066211063391] [Reference Citation Analysis]
9 Moreno G, Rodríguez A, Sole-Violán J, Martín-Loeches I, Díaz E, Bodí M, Reyes LF, Gómez J, Guardiola J, Trefler S, Vidaur L, Papiol E, Socias L, García-Vidal C, Correig E, Marín-Corral J, Restrepo MI, Nguyen-Van-Tam JS, Torres A. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia. ERJ Open Res 2021;7:00888-2020. [PMID: 33718494 DOI: 10.1183/23120541.00888-2020] [Reference Citation Analysis]
10 El Feghaly RE, Nolen JD, Lee BR, Abraham G, Nedved A, Hassan F, Selvarangan R. Impact of Rapid Influenza Molecular Testing on Management in Pediatric Acute Care Settings. J Pediatr 2021;228:271-277.e1. [PMID: 32828881 DOI: 10.1016/j.jpeds.2020.08.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Boyd DF, Wilson TL, Thomas PG. One hundred years of (influenza) immunopathology. Adv Virus Res 2020;107:247-84. [PMID: 32711731 DOI: 10.1016/bs.aivir.2020.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wallick C, Wu N, To TM, Keebler D, Moawad D. Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs. J Med Econ 2021;24:386-93. [PMID: 33571032 DOI: 10.1080/13696998.2021.1889572] [Reference Citation Analysis]
13 Alhumaid S, Al Mutair A, Al Alawi Z, Alshawi AM, Alomran SA, Almuhanna MS, Almuslim AA, Bu Shafia AH, Alotaibi AM, Ahmed GY, Rabaan AA, Al-Tawfiq JA, Al-Omari A. Coinfections with Bacteria, Fungi, and Respiratory Viruses in Patients with SARS-CoV-2: A Systematic Review and Meta-Analysis. Pathogens 2021;10:809. [PMID: 34202114 DOI: 10.3390/pathogens10070809] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Ren Y, Chen Y, Cao S. Targeted inhibition of the endonuclease activity of influenza polymerase acidic proteins. Future Med Chem 2022. [PMID: 35213253 DOI: 10.4155/fmc-2021-0264] [Reference Citation Analysis]
15 Spagnolello O, Pierangeli A, Cedrone MC, Di Biagio V, Gentile M, Leonardi A, Valeriano C, Innocenti GP, Santinelli L, Borrazzo C, Russo A, Oliveto G, Viscido A, Ciccozzi M, Bertazzoni G, d'Ettorre G, Ceccarelli G. Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age. J Med Virol 2021;93:4399-404. [PMID: 33783850 DOI: 10.1002/jmv.26980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Motisi MA, Tamborino A, Parigi S, Galli L, de Martino M, Chiappini E. The use of antiviral drugs in children. J Chemother 2021;:1-14. [PMID: 34633268 DOI: 10.1080/1120009X.2021.1979746] [Reference Citation Analysis]
17 Aberegg SK, Maddock SD, Blagev DP, Callahan SJ. Diagnosis of EVALI: General Approach and the Role of Bronchoscopy. Chest 2020;158:820-7. [PMID: 32092322 DOI: 10.1016/j.chest.2020.02.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
18 Gavrilova AA, Bontsevich RA, Vovk YR, Balabanova AA. Modern approaches to pharmacotherapy of Community-Acquired Pneumonia. RRP 2020;6:77-84. [DOI: 10.3897/rrpharmacology.6.52318] [Reference Citation Analysis]
19 Tatarelli P, Magnasco L, Borghesi ML, Russo C, Marra A, Mirabella M, Sarteschi G, Ungaro R, Arcuri C, Murialdo G, Viscoli C, Del Bono V, Nicolini LA. Prevalence and clinical impact of VIral Respiratory tract infections in patients hospitalized for Community-Acquired Pneumonia: the VIRCAP study. Intern Emerg Med 2020;15:645-54. [DOI: 10.1007/s11739-019-02243-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Au Yeung V, Thapa K, Rawlinson W, Georgiou A, Post JJ, Overton K. Differences in antibiotic and antiviral use in people with confirmed influenza: a retrospective comparison of rapid influenza PCR and multiplex respiratory virus PCR tests. BMC Infect Dis 2021;21:321. [PMID: 33827458 DOI: 10.1186/s12879-021-06030-w] [Reference Citation Analysis]
21 Campbell AM, Vraney J, Oman N, Xie C, Erstad BL. Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices. Ann Pharmacother 2021;55:265-6. [PMID: 32674586 DOI: 10.1177/1060028020942513] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Richard SA, Danaher PJ, White B, Mende K, Colombo RE, Burgess TH, Coles CL. Respiratory Infections Are More Common Than Healthcare Records Indicate: Results From an Anonymous Survey. Mil Med 2022:usac016. [PMID: 35134203 DOI: 10.1093/milmed/usac016] [Reference Citation Analysis]
23 Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care 2019;23:258. [PMID: 31324202 DOI: 10.1186/s13054-019-2539-x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 29.7] [Reference Citation Analysis]
24 Hillaker E, Belfer JJ, Bondici A, Murad H, Dumkow LE. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient. Pharmacotherapy 2020;40:592-8. [PMID: 32281114 DOI: 10.1002/phar.2403] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 18.0] [Reference Citation Analysis]
25 Czaja CA, Miller L, Alden N, Wald HL, Cummings CN, Rolfes MA, Anderson EJ, Bennett NM, Billing LM, Chai SJ, Eckel S, Mansmann R, McMahon M, Monroe ML, Muse A, Risk I, Schaffner W, Thomas AR, Yousey-Hindes K, Garg S, Herlihy RK. Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza-U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET). Open Forum Infect Dis 2019;6:ofz225. [PMID: 31363771 DOI: 10.1093/ofid/ofz225] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
26 Del Rosario JMM, da Costa KAS, Asbach B, Ferrara F, Ferrari M, Wells DA, Mann GS, Ameh VO, Sabeta CT, Banyard AC, Kinsley R, Scott SD, Wagner R, Heeney JL, Carnell GW, Temperton NJ. Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection. Vaccines (Basel) 2021;9:741. [PMID: 34358157 DOI: 10.3390/vaccines9070741] [Reference Citation Analysis]
27 Sherman AC, Mehta A, Dickert NW, Anderson EJ, Rouphael N. The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology. Front Cell Infect Microbiol 2019;9:107. [PMID: 31065546 DOI: 10.3389/fcimb.2019.00107] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
28 Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, Albuquerque A, Allocca M, Esteve M, Farraye FA, Gordon H, Karmiris K, Kopylov U, Kirchgesner J, MacMahon E, Magro F, Maaser C, de Ridder L, Taxonera C, Toruner M, Tremblay L, Scharl M, Viget N, Zabana Y, Vavricka S. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis 2021;15:879-913. [PMID: 33730753 DOI: 10.1093/ecco-jcc/jjab052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
29 Rajput R, Sharma J. SARS-CoV-2 in Pregnancy: Fitting Into the Existing Viral Repertoire. Front Glob Womens Health 2021;2:647836. [PMID: 34816202 DOI: 10.3389/fgwh.2021.647836] [Reference Citation Analysis]
30 Nypaver C, Dehlinger C, Carter C. Influenza and Influenza Vaccine: A Review. J Midwifery Womens Health 2021;66:45-53. [PMID: 33522695 DOI: 10.1111/jmwh.13203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Hsu YL, Lin HC, Wei HM, Lai HC, Hwang KP. One benefit of COVID-19 measures in Taiwan: The reduction of influenza infections and severe complications. Influenza Other Respir Viruses 2020;14:757-8. [PMID: 32875675 DOI: 10.1111/irv.12778] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Kim HJ. Novel respiratory infectious diseases in Korea. Yeungnam Univ J Med 2020;37:286-95. [PMID: 33045803 DOI: 10.12701/yujm.2020.00633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Zhang Y, Cao L, Xu Z, Zhu P, Huang B, Li K, Xu Y, Zhang Z, Wu Y, Di B. Evaluation of a multiplex PCR assay for detection of respiratory viruses and Mycoplasma pneumoniae in oropharyngeal swab samples from outpatients. J Clin Lab Anal 2020;34:e23032. [PMID: 31628684 DOI: 10.1002/jcla.23032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Mostafa HH, Carroll KC, Hicken R, Berry GJ, Manji R, Smith E, Rakeman JL, Fowler RC, Leelawong M, Butler-Wu SM, Quintero D, Umali-Wilcox M, Kwiatkowski RW, Persing DH, Weir F, Loeffelholz MJ. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test. J Clin Microbiol 2021;59:e02955-20. [PMID: 33298613 DOI: 10.1128/JCM.02955-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
35 Yousefi B, Valizadeh S, Ghaffari H, Vahedi A, Karbalaei M, Eslami M. A global treatments for coronaviruses including COVID-19. J Cell Physiol 2020;235:9133-42. [PMID: 32394467 DOI: 10.1002/jcp.29785] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 13.5] [Reference Citation Analysis]
36 Stellrecht KA, Cimino JL, Wilson LI, Maceira VP, Butt SA. Panther Fusion® Respiratory Virus Assays for the detection of influenza and other respiratory viruses. J Clin Virol 2019;121:104204. [PMID: 31743836 DOI: 10.1016/j.jcv.2019.104204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Naudion P, Lepiller Q, Bouiller K. Risk factors and clinical characteristics of patients with nosocomial influenza A infection. J Med Virol 2020;92:1047-52. [PMID: 31825110 DOI: 10.1002/jmv.25652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
38 Coffin SE, Lee GM. Mind the Gap: Spanning the Great Divide Between Perceived and Measured Value of Infectious Disease Physicians. J Pediatric Infect Dis Soc 2019;8:276-8. [PMID: 31006812 DOI: 10.1093/jpids/piz020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Cinesi Gómez C, Peñuelas Rodríguez Ó, Luján Torné M, Egea Santaolalla C, Masa Jiménez JF, García Fernández J, Carratalá Perales JM, Heili-Frades SB, Ferrer Monreal M, de Andrés Nilsson JM, Lista Arias E, Sánchez Rocamora JL, Garrote JI, Zamorano Serrano MJ, González Martínez M, Farrero Muñoz E, Mediano San Andrés O, Rialp Cervera G, Mas Serra A, Hernández Martínez G, de Haro López C, Roca Gas O, Ferrer Roca R, Romero Berrocal A, Ferrando Ortola C. [Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection]. Med Intensiva (Engl Ed) 2020;44:429-38. [PMID: 32312600 DOI: 10.1016/j.medin.2020.03.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
40 MacLaren R, Francisco J, Fetters M, Brady J, Kim C, Welker C. Oseltamivir-Associated Bradycardia in Critically Ill Patients. Ann Pharmacother 2021;55:1318-25. [PMID: 33615828 DOI: 10.1177/1060028020988919] [Reference Citation Analysis]
41 Parčina M, Schneider UV, Visseaux B, Jozić R, Hannet I, Lisby JG. Multicenter evaluation of the QIAstat Respiratory Panel-A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections. PLoS One 2020;15:e0230183. [PMID: 32163484 DOI: 10.1371/journal.pone.0230183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
42 Bandara T, Musto R, Kancir J, Neudorf C. Public health physician perspectives on developing and deploying clinical practice guidelines during the 2009 H1N1 pandemic. Healthc Manage Forum 2020;33:178-81. [PMID: 32250656 DOI: 10.1177/0840470420917412] [Reference Citation Analysis]
43 Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota JI, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A. Clinical manifestations of adult patients requiring influenza-associated hospitalization: A prospective multicenter cohort study in Japan via internet surveillance. J Infect Chemother 2021;27:480-5. [PMID: 33189538 DOI: 10.1016/j.jiac.2020.10.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Mutlu P, Mirici A, Gönlügür U, Oztoprak B, Özer Ş, Reşorlu M, Akçali A, Ülker Çakir D, Doğan CR. Evaluating the clinical, radiological, microbiological, biochemical parameters and the treatment response in COVID-19 pneumonia. Journal of Health Sciences and Medicine 2022;5:544-51. [DOI: 10.32322/jhsm.1035790] [Reference Citation Analysis]
45 Ftouh M, Kalboussi N, Abid N, Sfar S, Mignet N, Bahloul B. Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses. PPAR Res 2021;2021:6741290. [PMID: 34721558 DOI: 10.1155/2021/6741290] [Reference Citation Analysis]
46 Sato Y, Nirasawa S, Saeki M, Yakuwa Y, Ono M, Kobayashi R, Nakafuri H, Murai R, Fujiya Y, Kuronuma K, Takahashi S. Comparative study of rapid antigen testing and two nucleic acid amplification tests for influenza virus detection. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.04.009] [Reference Citation Analysis]
47 Chedid M, Waked R, Haddad E, Chetata N, Saliba G, Choucair J. Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy. J Infect Public Health 2021;14:570-6. [PMID: 33848886 DOI: 10.1016/j.jiph.2021.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
48 Couillard S, Connolly C, Borg C, Pavord I. Asthma in pregnancy: An update. Obstet Med 2021;14:135-44. [PMID: 34646341 DOI: 10.1177/1753495X20965072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Yang K, Zhang N, Gao C, Qin H, Wang A, Song L. Risk factors for hospital-acquired influenza A and patient characteristics: a matched case-control study. BMC Infect Dis 2020;20:863. [PMID: 33213361 DOI: 10.1186/s12879-020-05580-9] [Reference Citation Analysis]
50 Chaudhari PP, Monuteaux MC, Pannaraj PS, Khemani RG, Bachur RG. Age-Stratified Risk of Critical Illness in Young Children Presenting to the Emergency Department with Suspected Influenza. J Pediatr 2019;215:132-138.e2. [PMID: 31561954 DOI: 10.1016/j.jpeds.2019.08.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Sytsma TT, Rittenberg JD, Maus TP, Air MEM, Mauck WD, Tiegs-Heiden CA, Fischer KM, Greenlund LS. Spinal Region Corticosteroid Injections are not associated with Increased Risk for Influenza. Spine J 2022:S1529-9430(22)00034-1. [PMID: 35121154 DOI: 10.1016/j.spinee.2022.01.014] [Reference Citation Analysis]
52 Yuan Y, Wang RT, Xia J, Cao HJ. Interventions for preventing influenza: An overview of Cochrane systematic reviews and a Bayesian network meta-analysis. J Integr Med 2021;19:503-14. [PMID: 34544670 DOI: 10.1016/j.joim.2021.09.001] [Reference Citation Analysis]
53 Sarzani R, Spannella F, Giulietti F, Di Pentima C, Giordano P, Giacometti A. Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence. Intern Emerg Med 2021. [PMID: 34718937 DOI: 10.1007/s11739-021-02860-3] [Reference Citation Analysis]
54 Collins JP, Campbell AP, Openo K, Farley MM, Cummings CN, Hill M, Schaffner W, Lindegren ML, Thomas A, Billing L, Bennett N, Spina N, Bargsten M, Lynfield R, Eckel S, Ryan P, Yousey-Hindes K, Herlihy R, Kirley PD, Garg S, Anderson EJ. Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011-2015. Clin Infect Dis 2020;70:2121-30. [PMID: 31298691 DOI: 10.1093/cid/ciz638] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
55 Luque-Paz D, Pronier C, Bayeh B, Jouneau S, Grolhier C, Le Bot A, Bénézit F, Thibault V, Tattevin P. Incidence and characteristics of nosocomial influenza in a country with low vaccine coverage. J Hosp Infect 2020;105:619-24. [PMID: 32540461 DOI: 10.1016/j.jhin.2020.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Ishiguro N, Morioka I, Nakano T, Furukawa M, Tanaka S, Kinoshita M, Manabe A. Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol. BMC Infect Dis 2021;21:777. [PMID: 34372769 DOI: 10.1186/s12879-021-06494-w] [Reference Citation Analysis]
57 Lafond KE, Praptiningsih CY, Mangiri A, Syarif M, Triada R, Mulyadi E, Septiawati C, Setiawaty V, Samaan G, Storms AD, Uyeki TM, Iuliano AD. Seasonal Influenza and Avian Influenza A(H5N1) Virus Surveillance among Inpatients and Outpatients, East Jakarta, Indonesia, 2011-2014. Emerg Infect Dis 2019;25:2031-9. [PMID: 31625837 DOI: 10.3201/eid2511.181844] [Reference Citation Analysis]
58 Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B. Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial. J Antimicrob Chemother 2021;76:iii20-7. [PMID: 34555158 DOI: 10.1093/jac/dkab241] [Reference Citation Analysis]
59 L'Huillier AG, Ferreira VH, Ku T, Bahinskaya I, Kumar D, Humar A. Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients. Am J Transplant 2019;19:2495-504. [PMID: 30916879 DOI: 10.1111/ajt.15371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
60 Divino V, Ruthwik Anupindi V, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ, Levin MJ. A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019-2020 Influenza Season in the United States. Open Forum Infect Dis 2022;9:ofab604. [PMID: 35028334 DOI: 10.1093/ofid/ofab604] [Reference Citation Analysis]
61 Dharmapalan D. Influenza. Indian J Pediatr 2020;87:828-32. [PMID: 32048225 DOI: 10.1007/s12098-020-03214-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
62 Punjabi CD, Madaline T, Gendlina I, Chen V, Nori P, Pirofski LA. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in respiratory cultures and diagnostic performance of the MRSA nasal polymerase chain reaction (PCR) in patients hospitalized with coronavirus disease 2019 (COVID-19) pneumonia. Infect Control Hosp Epidemiol 2020;:1-2. [PMID: 32843125 DOI: 10.1017/ice.2020.440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
63 Cinesi Gómez C, Peñuelas Rodríguez Ó, Luján Torné ML, Egea Santaolalla C, Masa Jiménez JF, García Fernández J, Carratalá Perales JM, Heili-Frades SB, Ferrer Monreal M, de Andrés Nilsson JM, Lista Arias E, Sánchez Rocamora JL, Garrote JI, Zamorano Serrano MJ, González Martínez M, Farrero Muñoz E, Mediano San Andrés O, Rialp Cervera G, Mas Serra A, Hernández Martínez G, de Haro López C, Roca Gas O, Ferrer Roca R, Romero Berrocal A, Ferrando Ortola C. Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection. Rev Esp Anestesiol Reanim (Engl Ed) 2020;67:261-70. [PMID: 32307151 DOI: 10.1016/j.redar.2020.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
64 Farfour E, Roux A, Ballester M, Gagneur L, Renaux C, Jolly E, Vasse M. Improved performances of the second generation of the ID NOW influenza A&B 2® and comparison with the GeneXpert®. Eur J Clin Microbiol Infect Dis 2020;39:1681-6. [DOI: 10.1007/s10096-020-03905-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
65 Ouchi D, García-Sangenís A, Moragas A, van der Velden AW, Verheij TJ, Butler CC, Bongard E, Coenen S, Cook J, Francis NA, Godycki-Cwirko M, Lundgren PT, Lionis C, Radzeviciene Jurgute R, Chlabicz S, De Sutter A, Bucher HC, Seifert B, Kovács B, de Paor M, Sundvall PD, Aabenhus R, Harbin NJ, Ieven G, Goossens H, Lindbæk M, Bjerrum L, Llor C. Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries. Fam Pract 2021:cmab122. [PMID: 34611715 DOI: 10.1093/fampra/cmab122] [Reference Citation Analysis]
66 Wils J, Saegeman V, Schuermans A. Impact of multiplexed respiratory viral panels on infection control measures and antimicrobial stewardship: a review of the literature. Eur J Clin Microbiol Infect Dis 2021. [PMID: 34799754 DOI: 10.1007/s10096-021-04375-3] [Reference Citation Analysis]
67 Lee JY, Baek SH, Ahn JG, Yoon SH, Kim MK, Kim SY, Kim KW, Sohn MH, Kang JM. Delayed Influenza Treatment in Children With False-Negative Rapid Antigen Test: A Retrospective Single-Center Study in Korea 2016-2019. J Korean Med Sci 2022;37:e3. [PMID: 34981679 DOI: 10.3346/jkms.2022.37.e3] [Reference Citation Analysis]
68 Lim VW, Tudor Car L, Leo YS, Chen MI, Young B. Passive immune therapy and other immunomodulatory agents for the treatment of severe influenza: Systematic review and meta-analysis. Influenza Other Respir Viruses 2020;14:226-36. [PMID: 31733048 DOI: 10.1111/irv.12699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
69 Day JD, Park S, Ranard BL, Singh H, Chow CC, Vodovotz Y. Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model. Front Immunol 2021;12:754127. [PMID: 34777366 DOI: 10.3389/fimmu.2021.754127] [Reference Citation Analysis]
70 Hamadah RE, Hussain AN, Alsoghayer NA, Alkhenizan ZA, Alajlan HA, Alkhenizan AH. Attitude of parents towards seasonal influenza vaccination for children in Saudi Arabia. J Family Med Prim Care 2021;10:904-9. [PMID: 34041096 DOI: 10.4103/jfmpc.jfmpc_1602_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Smith BJ, Price DJ, Johnson D, Garbutt B, Thompson M, Irving LB, Putland M, Tong SYC. Influenza With and Without Fever: Clinical Predictors and Impact on Outcomes in Patients Requiring Hospitalization. Open Forum Infect Dis 2020;7:ofaa268. [PMID: 33123614 DOI: 10.1093/ofid/ofaa268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Ewig S, Kolditz M, Pletz M, Altiner A, Albrich W, Drömann D, Flick H, Gatermann S, Krüger S, Nehls W, Panning M, Rademacher J, Rohde G, Rupp J, Schaaf B, Heppner HJ, Krause R, Ott S, Welte T, Witzenrath M. [Management of Adult Community-Acquired Pneumonia and Prevention - Update 2021 - Guideline of the German Respiratory Society (DGP), the Paul-Ehrlich-Society for Chemotherapy (PEG), the German Society for Infectious Diseases (DGI), the German Society of Medical Intensive Care and Emergency Medicine (DGIIN), the German Viological Society (DGV), the Competence Network CAPNETZ, the German College of General Practitioneers and Family Physicians (DEGAM), the German Society for Geriatric Medicine (DGG), the German Palliative Society (DGP), the Austrian Society of Pneumology Society (ÖGP), the Austrian Society for Infectious and Tropical Diseases (ÖGIT), the Swiss Respiratory Society (SGP) and the Swiss Society for Infectious Diseases Society (SSI)]. Pneumologie 2021. [PMID: 34198346 DOI: 10.1055/a-1497-0693] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 FakhriRavari A, Jin S, Kachouei FH, Le D, Lopez M. Systemic corticosteroids for management of COVID-19: Saving lives or causing harm? Int J Immunopathol Pharmacol 2021;35:20587384211063976. [PMID: 34923856 DOI: 10.1177/20587384211063976] [Reference Citation Analysis]
74 Coste A, Frérou A, Raute A, Couturaud F, Morin J, Egreteau PY, Blanc FX, Reignier J, Tadié JM, Tran A, Pronier C, Coste-Burel M, Nevez G, Gangneux JP, Le Pape P, Ansart S, Tonnelier JM, Bretonnière C, Aubron C. The Extent of Aspergillosis in Critically Ill Patients With Severe Influenza Pneumonia: A Multicenter Cohort Study. Crit Care Med 2021;49:934-42. [PMID: 33591000 DOI: 10.1097/CCM.0000000000004861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Rothe K, Spinner CD, Panning M, Pletz MW, Rohde G, Rupp J, Witzenrath M, Erber J, Eberhardt F, Essig A, Schneider J; Members of the CAPNETZ study group. Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ). Infection 2021;49:1299-306. [PMID: 34687426 DOI: 10.1007/s15010-021-01720-8] [Reference Citation Analysis]
76 Haddadin Z, Krueger K, Thomas LD, Overton ET, Ison M, Halasa N. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. Am J Transplant 2021;21:938-49. [PMID: 32885604 DOI: 10.1111/ajt.16295] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
77 Delgado A, Guddati AK. Infections in Hospitalized Cancer Patients. World J Oncol 2021;12:195-205. [PMID: 35059079 DOI: 10.14740/wjon1410] [Reference Citation Analysis]
78 Miyashita K, Nakatani E, Hozumi H, Sato Y, Miyachi Y, Suda T. Risk Factors for Pneumonia and Death in Adult Patients With Seasonal Influenza and Establishment of Prediction Scores: A Population-Based Study. Open Forum Infect Dis 2021;8:ofab068. [PMID: 33738319 DOI: 10.1093/ofid/ofab068] [Reference Citation Analysis]
79 Wæhre T, Tunheim G, Bodin JE, Laake I, Kvale D, Kran AB, Brekke H, Løken R, Oftung F, Mjaaland S, Dyrhol-Riise AM. Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014-2018. Infect Dis (Lond) 2022;:1-11. [PMID: 34983302 DOI: 10.1080/23744235.2021.2022196] [Reference Citation Analysis]
80 Jones TE. Oseltamivir-Current Dosing Recommendations Reduce the Therapeutic Benefit in Patients With Mild to Moderate Renal Function and/or Large Body Mass: A Review of the Literature With Recommendations to Optimize Dosing, Including the Use of Therapeutic Drug Monitoring. Ther Drug Monit 2021;43:103-7. [PMID: 32947554 DOI: 10.1097/FTD.0000000000000797] [Reference Citation Analysis]
81 Smith ER, Fry AM, Hicks LA, Fleming-Dutra KE, Flannery B, Ferdinands J, Rolfes MA, Martin ET, Monto AS, Zimmerman RK, Nowalk MP, Jackson ML, McLean HQ, Olson SC, Gaglani M, Patel MM. Reducing Antibiotic Use in Ambulatory Care Through Influenza Vaccination. Clin Infect Dis 2020;71:e726-34. [PMID: 32322875 DOI: 10.1093/cid/ciaa464] [Reference Citation Analysis]
82 Chow EJ, Rolfes MA, O'Halloran A, Alden NB, Anderson EJ, Bennett NM, Billing L, Dufort E, Kirley PD, George A, Irizarry L, Kim S, Lynfield R, Ryan P, Schaffner W, Talbot HK, Thomas A, Yousey-Hindes K, Reed C, Garg S. Respiratory and Nonrespiratory Diagnoses Associated With Influenza in Hospitalized Adults. JAMA Netw Open 2020;3:e201323. [PMID: 32196103 DOI: 10.1001/jamanetworkopen.2020.1323] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
83 Linli Z, Chen Y, Tian G, Guo S, Fei Y. Identifying and quantifying robust risk factors for mortality in critically ill patients with COVID-19 using quantile regression. Am J Emerg Med 2021;45:345-51. [PMID: 33046291 DOI: 10.1016/j.ajem.2020.08.090] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Bolge SC, Kariburyo F, Yuce H, Fleischhackl R. Predictors and Outcomes of Hospitalization for Influenza: Real-World Evidence from the United States Medicare Population. Infect Dis Ther 2021;10:213-28. [PMID: 33108613 DOI: 10.1007/s40121-020-00354-x] [Reference Citation Analysis]
85 Liu JW, Lin SH, Wang LC, Chiu HY, Lee JA. Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children: A Systematic Review and Network Meta-analysis. JAMA Netw Open 2021;4:e2119151. [PMID: 34387680 DOI: 10.1001/jamanetworkopen.2021.19151] [Reference Citation Analysis]
86 Su HC, Feng IJ, Tang HJ, Shih MF, Hua YM. Comparative effectiveness of neuraminidase inhibitors in patients with influenza: A systematic review and network meta-analysis. J Infect Chemother 2021:S1341-321X(21)00325-1. [PMID: 34840038 DOI: 10.1016/j.jiac.2021.11.014] [Reference Citation Analysis]
87 Zigman Suchsland ML, Rahmatullah I, Lutz B, Lyon V, Huang S, Kline E, Graham C, Cooper S, Su P, Smedinghoff S, Chu HY, Sewalk K, Brownstein JS, Thompson MJ; Seattle Flu Study investigators. Evaluating an app-guided self-test for influenza: lessons learned for improving the feasibility of study designs to evaluate self-tests for respiratory viruses. BMC Infect Dis 2021;21:617. [PMID: 34187397 DOI: 10.1186/s12879-021-06314-1] [Reference Citation Analysis]
88 Zhan Y, Chen X, Guan W, Guan W, Yang C, Pan S, Wong SS, Chen R, Ye F. Clinical impact of nosocomial infection with pandemic influenza A (H1N1) 2009 in a respiratory ward in Guangzhou. J Thorac Dis 2021;13:5851-62. [PMID: 34795934 DOI: 10.21037/jtd-21-897] [Reference Citation Analysis]
89 O'Kelly B, Conway A, McNally C, McConkey S, Kelly A, de Barra E. Rapid diagnosis of seasonal Influenza virus and cohorting of hospitalised patients on a 'flu ward'. A prospective analysis of outcomes. J Hosp Infect 2020:S0195-6701(20)30122-5. [PMID: 32311407 DOI: 10.1016/j.jhin.2020.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Benedict K, Kobayashi M, Garg S, Chiller T, Jackson BR. Symptoms in blastomycosis, coccidioidomycosis, and histoplasmosis versus other respiratory illnesses in commercially insured adult outpatients, United States, 2016-2017. Clin Infect Dis 2020:ciaa1554. [PMID: 33053180 DOI: 10.1093/cid/ciaa1554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Bouzid D, Lucet JC, Duval X, Houhou-Fidouh N, Casalino E, Visseaux B; ED Influenza Management Study Group. Multiplex PCR implementation as point-of-care testing in a French emergency department. J Hosp Infect 2020;105:337-8. [PMID: 32032615 DOI: 10.1016/j.jhin.2020.01.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
92 Gu Y, Zuo X, Zhang S, Ouyang Z, Jiang S, Wang F, Wang G. The Mechanism behind Influenza Virus Cytokine Storm. Viruses 2021;13:1362. [PMID: 34372568 DOI: 10.3390/v13071362] [Reference Citation Analysis]
93 Checovich MM, Barlow S, Shult P, Reisdorf E, Temte JL. Evaluation of Viruses Associated With Acute Respiratory Infections in Long-Term Care Facilities Using a Novel Method: Wisconsin, 2016‒2019. J Am Med Dir Assoc 2020;21:29-33. [PMID: 31636034 DOI: 10.1016/j.jamda.2019.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Jones BE, Herman DD, Dela Cruz CS, Waterer GW, Metlay JP, Ruminjo JK, Thomson CC. Summary for Clinicians: Clinical Practice Guideline for the Diagnosis and Treatment of Community-acquired Pneumonia. Ann Am Thorac Soc 2020;17:133-8. [PMID: 31770496 DOI: 10.1513/AnnalsATS.201909-704CME] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Assaf-Casals A, Saleh Z, Khafaja S, Fayad D, Ezzeddine H, Saleh M, Chamseddine S, Sayegh R, Sharara SL, Chmaisse A, Kanj SS, Kanafani Z, Hanna-Wakim R, Araj GF, Mahfouz R, Saito R, Suzuki H, Zaraket H, Dbaibo GS. The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience. BMC Infect Dis 2020;20:339. [PMID: 32397965 DOI: 10.1186/s12879-020-05013-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Okamori S, Ishii M, Asakura T, Suzuki S, Namkoong H, Kagawa S, Hegab AE, Yagi K, Kamata H, Kusumoto T, Ogawa T, Takahashi H, Yoda M, Horiuchi K, Hasegawa N, Fukunaga K. ADAM10 partially protects mice against influenza pneumonia by suppressing specific myeloid cell population. Am J Physiol Lung Cell Mol Physiol 2021;321:L872-84. [PMID: 34523355 DOI: 10.1152/ajplung.00619.2020] [Reference Citation Analysis]
97 Seneghini M, Albrich W. [58/m-fever, cough and severe hypoxemia : Preparation for the medical specialist examination: part 65]. Internist (Berl) 2021;62:435-9. [PMID: 34264361 DOI: 10.1007/s00108-021-01096-9] [Reference Citation Analysis]
98 Piñana J, Montoro J, Aznar C, Lorenzo I, Gómez MD, Guerreiro M, Carretero C, González-Barberá EM, Balaguer-Roselló A, Sanz R, Salavert M, Navarro D, Sanz MA, Sanz G, Sanz J. The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation. J Infect 2020;80:333-41. [PMID: 31972212 DOI: 10.1016/j.jinf.2019.12.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
99 Lane CJ, Bhatnagar M, Lutrick K, Maves RC, Weiner D, Rios Olvera D, Uyeki TM, Cobb JP, Brown JC. ICU Resource Limitations During Peak Seasonal Influenza: Results of a 2018 National Feasibility Study. Crit Care Explor 2022;4:e0606. [PMID: 35018345 DOI: 10.1097/CCE.0000000000000606] [Reference Citation Analysis]
100 Bassetti M, Castaldo N, Carnelutti A. Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives. Expert Opin Pharmacother 2019;20:1711-8. [PMID: 31169040 DOI: 10.1080/14656566.2019.1626824] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
101 Tang X, Du RH, Wang R, Cao TZ, Guan LL, Yang CQ, Zhu Q, Hu M, Li XY, Li Y, Liang LR, Tong ZH, Sun B, Peng P, Shi HZ. Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1. Chest. 2020;158:195-205. [PMID: 32224074 DOI: 10.1016/j.chest.2020.03.032] [Cited by in Crossref: 167] [Cited by in F6Publishing: 146] [Article Influence: 83.5] [Reference Citation Analysis]
102 Taieb V, Ikeoka H, Wojciechowski P, Jablonska K, Aballea S, Hill M, Hirotsu N. Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients - a Bayesian network meta-analysis. Curr Med Res Opin 2021;37:225-44. [PMID: 33079575 DOI: 10.1080/03007995.2020.1839400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Pronier C, Gacouin A, Lagathu G, Le Tulzo Y, Tadié J, Thibault V. Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms. Journal of Clinical Virology 2021;136:104761. [DOI: 10.1016/j.jcv.2021.104761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Chow EJ, Beigi RH, Riley LE, Uyeki TM. Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy. Open Forum Infect Dis 2021;8:ofab138. [PMID: 34189160 DOI: 10.1093/ofid/ofab138] [Reference Citation Analysis]
105 de St Maurice A, Martin-Blais R, Halasa N. Preparing for the 2020-2021 influenza season. Pediatr Transplant 2021;25:e14025. [PMID: 33904211 DOI: 10.1111/petr.14025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Şimşek Yavuz S, Ünal S. Antiviral treatment of COVID-19. Turk J Med Sci 2020;50:611-9. [PMID: 32293834 DOI: 10.3906/sag-2004-145] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 46.0] [Reference Citation Analysis]
107 Tenforde MW, Campbell AP, Michaels MG, Harrison CJ, Klein EJ, Englund JA, Selvarangan R, Halasa NB, Stewart LS, Weinberg GA, Williams JV, Szilagyi PG, Staat MA, Boom JA, Sahni LC, Singer MN, Azimi PH, Zimmerman RK, McNeal MM, Talbot HK, Monto AS, Martin ET, Gaglani M, Silveira FP, Middleton DB, Ferdinands JM, Rolfes MA. Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018. J Pediatric Infect Dis Soc 2021:piab096. [PMID: 34643241 DOI: 10.1093/jpids/piab096] [Reference Citation Analysis]
108 Krishnarajah G, Divino V, Postma MJ, Pelton SI, Anupindi VR, DeKoven M, Mould-Quevedo J. Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States. Vaccines (Basel) 2021;9:80. [PMID: 33498724 DOI: 10.3390/vaccines9020080] [Reference Citation Analysis]
109 Simpson RB, Gottlieb J, Zhou B, Hartwick MA, Naumova EN. Completeness of open access FluNet influenza surveillance data for Pan-America in 2005-2019. Sci Rep 2021;11:795. [PMID: 33437025 DOI: 10.1038/s41598-020-80842-9] [Reference Citation Analysis]
110 Yoshii N, Tochino Y, Fujioka M, Sakazaki H, Maruyama N, Asai K, Kakeya H, Shintaku H, Kawaguchi T. The Comparison of the Efficacy of Baloxavir and Neuraminidase Inhibitors for Patients with Influenza A in Clinical Practice. Intern Med 2020;59:1509-13. [PMID: 32536677 DOI: 10.2169/internalmedicine.4117-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
111 Venkatesh A, Patel R, Goyal S, Rajaratnam T, Sharma A, Hossain P. Ocular manifestations of emerging viral diseases. Eye (Lond) 2021;35:1117-39. [PMID: 33514902 DOI: 10.1038/s41433-020-01376-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
112 Sangkakam A, Hemachudha P, Saraya AW, Thaweethee-Sukjai B, Cheun-Arom T, Latinne A, Olival KJ, Wacharapluesadee S. Detection of influenza virus in rectal swabs of patients admitted in hospital for febrile illnesses in Thailand. SAGE Open Med 2021;9:2050312121989631. [PMID: 33552519 DOI: 10.1177/2050312121989631] [Reference Citation Analysis]
113 Cinesi Gómez C, Peñuelas Rodríguez Ó, Luján Torné M, Egea Santaolalla C, Masa Jiménez JF, García Fernández J, Carratalá Perales JM, Heili-Frades SB, Ferrer Monreal M, de Andrés Nilsson JM, Lista Arias E, Sánchez Rocamora JL, Garrote JI, Zamorano Serrano MJ, González Martínez M, Farrero Muñoz E, Mediano San Andrés O, Rialp Cervera G, Mas Serra A, Hernández Martínez G, de Haro López C, Roca Gas O, Ferrer Roca R, Romero Berrocal A, Ferrando Ortola C. Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection. Arch Bronconeumol 2020;56 Suppl 2:11-8. [PMID: 32336563 DOI: 10.1016/j.arbres.2020.03.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
114 Venkatram S, Alapati A, Dileep A, Diaz-Fuentes G. Change in patterns of hospitalization for influenza during COVID-19 surges. Influenza Other Respir Viruses 2021. [PMID: 34427056 DOI: 10.1111/irv.12900] [Reference Citation Analysis]
115 Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, Kakihana Y, Kawasaki T, Kushimoto S, Kuroda Y, Kotani J, Shime N, Taniguchi T, Tsuruta R, Doi K, Doi M, Nakada TA, Nakane M, Fujishima S, Hosokawa N, Masuda Y, Matsushima A, Matsuda N, Yamakawa K, Hara Y, Sakuraya M, Ohshimo S, Aoki Y, Inada M, Umemura Y, Kawai Y, Kondo Y, Saito H, Taito S, Takeda C, Terayama T, Tohira H, Hashimoto H, Hayashida K, Hifumi T, Hirose T, Fukuda T, Fujii T, Miura S, Yasuda H, Abe T, Andoh K, Iida Y, Ishihara T, Ide K, Ito K, Ito Y, Inata Y, Utsunomiya A, Unoki T, Endo K, Ouchi A, Ozaki M, Ono S, Katsura M, Kawaguchi A, Kawamura Y, Kudo D, Kubo K, Kurahashi K, Sakuramoto H, Shimoyama A, Suzuki T, Sekine S, Sekino M, Takahashi N, Takahashi S, Takahashi H, Tagami T, Tajima G, Tatsumi H, Tani M, Tsuchiya A, Tsutsumi Y, Naito T, Nagae M, Nagasawa I, Nakamura K, Nishimura T, Nunomiya S, Norisue Y, Hashimoto S, Hasegawa D, Hatakeyama J, Hara N, Higashibeppu N, Furushima N, Furusono H, Matsuishi Y, Matsuyama T, Minematsu Y, Miyashita R, Miyatake Y, Moriyasu M, Yamada T, Yamada H, Yamamoto R, Yoshida T, Yoshida Y, Yoshimura J, Yotsumoto R, Yonekura H, Wada T, Watanabe E, Aoki M, Asai H, Abe T, Igarashi Y, Iguchi N, Ishikawa M, Ishimaru G, Isokawa S, Itakura R, Imahase H, Imura H, Irinoda T, Uehara K, Ushio N, Umegaki T, Egawa Y, Enomoto Y, Ota K, Ohchi Y, Ohno T, Ohbe H, Oka K, Okada N, Okada Y, Okano H, Okamoto J, Okuda H, Ogura T, Onodera Y, Oyama Y, Kainuma M, Kako E, Kashiura M, Kato H, Kanaya A, Kaneko T, Kanehata K, Kano KI, Kawano H, Kikutani K, Kikuchi H, Kido T, Kimura S, Koami H, Kobashi D, Saiki I, Sakai M, Sakamoto A, Sato T, Shiga Y, Shimoto M, Shimoyama S, Shoko T, Sugawara Y, Sugita A, Suzuki S, Suzuki Y, Suhara T, Sonota K, Takauji S, Takashima K, Takahashi S, Takahashi Y, Takeshita J, Tanaka Y, Tampo A, Tsunoyama T, Tetsuhara K, Tokunaga K, Tomioka Y, Tomita K, Tominaga N, Toyosaki M, Toyoda Y, Naito H, Nagata I, Nagato T, Nakamura Y, Nakamori Y, Nahara I, Naraba H, Narita C, Nishioka N, Nishimura T, Nishiyama K, Nomura T, Haga T, Hagiwara Y, Hashimoto K, Hatachi T, Hamasaki T, Hayashi T, Hayashi M, Hayamizu A, Haraguchi G, Hirano Y, Fujii R, Fujita M, Fujimura N, Funakoshi H, Horiguchi M, Maki J, Masunaga N, Matsumura Y, Mayumi T, Minami K, Miyazaki Y, Miyamoto K, Murata T, Yanai M, Yano T, Yamada K, Yamada N, Yamamoto T, Yoshihiro S, Tanaka H, Nishida O. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). J Intensive Care 2021;9:53. [PMID: 34433491 DOI: 10.1186/s40560-021-00555-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Qiu L, Wu XW, Zhang SY, Yang M, Zhang SX, Fu JY, Li C, Zhang ZJ, Zheng PY, Lu ZH. Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trial. Trials 2021;22:955. [PMID: 34961550 DOI: 10.1186/s13063-021-05929-8] [Reference Citation Analysis]
117 Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y, van Bentum-Puijk W, Bhimani Z, Bonten M, Broglio K, Brunkhorst F, Cheng AC, Chiche JD, De Jong M, Detry M, Goossens H, Gordon A, Green C, Higgins AM, Hullegie SJ, Kruger P, Lamontagne F, Litton E, Marshall J, McGlothlin A, McGuinness S, Mouncey P, Murthy S, Nichol A, O'Neill GK, Parke R, Parker J, Rohde G, Rowan K, Turner A, Young P, Derde L, McArthur C, Webb SA. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc 2020;17:879-91. [PMID: 32267771 DOI: 10.1513/AnnalsATS.202003-192SD] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 37.5] [Reference Citation Analysis]
118 McCartney SA, Kachikis A, Huebner EM, Walker CL, Chandrasekaran S, Adams Waldorf KM. Obesity as a contributor to immunopathology in pregnant and non-pregnant adults with COVID-19. Am J Reprod Immunol 2020;84:e13320. [PMID: 32779790 DOI: 10.1111/aji.13320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
119 Bogdan I, Citu C, Bratosin F, Malita D, Romosan I, Gurban CV, Bota AV, Turaiche M, Bratu ML, Pilut CN, Marincu I. The Impact of Multiplex PCR in Diagnosing and Managing Bacterial Infections in COVID-19 Patients Self-Medicated with Antibiotics. Antibiotics 2022;11:437. [DOI: 10.3390/antibiotics11040437] [Reference Citation Analysis]
120 Bourgeois M, Ausselet N, Gerard V, de Canniere L, Scius N, Michaux I, Huang TD, Bogaerts P, Vandamme C, Bihin B, Delaere B. Severe influenza/respiratory syncytial virus infections and hospital antimicrobial stewardship opportunities: impact of a 4-year surveillance including molecular diagnosis. Infect Control Hosp Epidemiol 2020;41:1184-9. [PMID: 32624029 DOI: 10.1017/ice.2020.260] [Reference Citation Analysis]
121 Macesic N, Laplante JM, Aaron JG, DiMango EA, Miko BA, Pereira MR, Reshef R, St George K. Baloxavir treatment of oseltamivir-resistant influenza A/H1pdm09 in two immunocompromised patients. Transpl Infect Dis 2021;23:e13542. [PMID: 33278052 DOI: 10.1111/tid.13542] [Reference Citation Analysis]
122 Chen L, Han X, Li YL, Zhang C, Xing X. The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study. BMC Infect Dis 2020;20:628. [PMID: 32842994 DOI: 10.1186/s12879-020-05322-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Whitley RJ, Monto AS. Resistance of Influenza Virus to Antiviral Medications. Clin Infect Dis 2020;71:1092-4. [PMID: 31538179 DOI: 10.1093/cid/ciz911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
124 Le Thi N, Ikuyo T, Nguyen Gia B, Truong Thai P, Vu Thi TV, Bui Minh V, Dao Xuan C, Le Trung D, Phan Thu P, Do Duy C, Pham The T, Do VT, Pham Thi PT, Ngo Quy C, Dang Quoc T, Jin T, Shohei S, Takato O, Noriko N, Tsutomu K. A clinic-based direct real-time fluorescent reverse transcription loop-mediated isothermal amplification assay for influenza virus. J Virol Methods 2020;277:113801. [PMID: 31838003 DOI: 10.1016/j.jviromet.2019.113801] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
125 Fang YH, Hsu TH, Lin TY, Liu CH, Chou SC, Wu JY, Perng PC. Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2021;19:1039-46. [PMID: 33641583 DOI: 10.1080/14787210.2021.1878025] [Reference Citation Analysis]
126 Kositpantawong N, Surasombatpattana S, Siripaitoon P, Kanchanasuwan S, Hortiwakul T, Charernmak B, Nwabor OF, Chusri S. Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia. PLoS One 2021;16:e0261411. [PMID: 34910777 DOI: 10.1371/journal.pone.0261411] [Reference Citation Analysis]
127 Mitra P, Suri S, Goyal T, Misra R, Singh K, Garg MK, Misra S, Sharma P; Abhilasha. Association of Comorbidities with Coronavirus Disease 2019: A Review. Annals of the National Academy of Medical Sciences (India) 2020;56:102-11. [DOI: 10.1055/s-0040-1714159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
128 Ferrer S, Sancho J, Bocigas I, Bures E, Mora H, Monclou E, Mulet A, Quezada A, Royo P, Signes-Costa J. ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2. Respir Med 2021;189:106638. [PMID: 34634500 DOI: 10.1016/j.rmed.2021.106638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Ren Y, Long S, Cao S. Molecular Docking and Virtual Screening of an Influenza Virus Inhibitor That Disrupts Protein-Protein Interactions. Viruses 2021;13:2229. [PMID: 34835035 DOI: 10.3390/v13112229] [Reference Citation Analysis]
130 Peaper DR, Branson B, Parwani V, Ulrich A, Shapiro MJ, Clemons C, Campbell M, Owen M, Martinello RA, Landry ML. Clinical impact of rapid influenza PCR in the adult emergency department on patient management, ED length of stay, and nosocomial infection rate. Influenza Other Respir Viruses 2021;15:254-61. [PMID: 32851793 DOI: 10.1111/irv.12800] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
131 Kanwar N, Michael J, Doran K, Montgomery E, Selvarangan R. Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children. J Clin Microbiol 2020;58:e01611-19. [PMID: 31941689 DOI: 10.1128/JCM.01611-19] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
132 Böncüoğlu E, Kıymet E, Çağlar İ, Tahta N, Bayram N, Ayhan FY, Genel F, Ecevit ÇÖ, Apa H, Çelik T, Devrim İ. Influenza-related hospitalizations due to acute lower respiratory tract infections in a tertiary care children's hospital in Turkey. J Clin Virol 2020;128:104355. [PMID: 32464308 DOI: 10.1016/j.jcv.2020.104355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Kuo YC, Lai CC, Wang YH, Chen CH, Wang CY. Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials. J Microbiol Immunol Infect 2021:S1684-1182(21)00092-X. [PMID: 34020891 DOI: 10.1016/j.jmii.2021.04.002] [Reference Citation Analysis]
134 Ventura CG, Roque FL, Sousa IQ, Lobo RD, Luders C. Influenza A (H1N1): outbreak management in a dialysis unit and clinical outcomes of infection in chronic hemodialysis patients. J Bras Nefrol 2020;42:182-90. [PMID: 32227069 DOI: 10.1590/2175-8239-jbn-2019-0180] [Reference Citation Analysis]
135 Martinon D, Borges VF, Gomez AC, Shimada K. Potential Fast COVID-19 Containment With Trehalose. Front Immunol 2020;11:1623. [PMID: 32733488 DOI: 10.3389/fimmu.2020.01623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
136 Laws HJ, Baumann U, Bogdan C, Burchard G, Christopeit M, Hecht J, Heininger U, Hilgendorf I, Kern W, Kling K, Kobbe G, Külper W, Lehrnbecher T, Meisel R, Simon A, Ullmann A, de Wit M, Zepp F. Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020;63:588-644. [PMID: 32350583 DOI: 10.1007/s00103-020-03123-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 7.5] [Reference Citation Analysis]
137 Ejima K, Kim KS, Iwanami S, Fujita Y, Li M, Zoh RS, Aihara K, Miyazaki T, Wakita T, Iwami S. Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model. J R Soc Interface 2021;18:20200947. [PMID: 33878277 DOI: 10.1098/rsif.2020.0947] [Reference Citation Analysis]
138 Selvanayagam S, Kang A, Ha D. Baloxavir Marboxil: A New Antiviral for Acute Influenza. J Contemp Pharm Pract 2020;66:33-8. [DOI: 10.37901/jcphp19-00004] [Reference Citation Analysis]
139 Esparza M, Mor A, Niederstrasser H, White K, White A, Zhang K, Gao S, Wang J, Liang J, Sho S, Sakthivel R, Sathe AA, Xing C, Muñoz-Moreno R, Shay JW, García-Sastre A, Ready J, Posner B, Fontoura BMA. Chemical intervention of influenza virus mRNA nuclear export. PLoS Pathog 2020;16:e1008407. [PMID: 32240278 DOI: 10.1371/journal.ppat.1008407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
140 Yildirim M, Serban N, Shih J, Keskinocak P. Reflecting on prediction strategies for epidemics: Preparedness and public health response. Ann Allergy Asthma Immunol 2021;126:338-49. [PMID: 33307158 DOI: 10.1016/j.anai.2020.11.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Hirotsu N, Sakaguchi H, Sato C, Ishibashi T, Baba K, Omoto S, Shishido T, Tsuchiya K, Hayden FG, Uehara T, Watanabe A. Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes. Clin Infect Dis 2020;71:971-81. [PMID: 31538644 DOI: 10.1093/cid/ciz908] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 48.0] [Reference Citation Analysis]
142 Torres A, Loeches IM, Sligl W, Lee N. Severe flu management: a point of view. Intensive Care Med 2020;46:153-62. [PMID: 31912206 DOI: 10.1007/s00134-019-05868-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
143 Bassetti M, Peghin M, Gallo T, Pipan C, D'Agaro P, Sartor A, Bove T, Cocconi R, Graziano E, Castaldo N. The burden of severe cases of Influenza disease: the Friuli Venezia Giulia Region experience. J Prev Med Hyg 2019;60:E163-70. [PMID: 31650049 DOI: 10.15167/2421-4248/jpmh2019.60.3.1314] [Reference Citation Analysis]
144 Shirley M. Baloxavir Marboxil: A Review in Acute Uncomplicated Influenza. Drugs 2020;80:1109-18. [PMID: 32601915 DOI: 10.1007/s40265-020-01350-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
145 Whitman J, Jayaprakash C. Stochastic modeling of influenza spread dynamics with recurrences. PLoS One 2020;15:e0231521. [PMID: 32315318 DOI: 10.1371/journal.pone.0231521] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Lalueza A, Ayuso B, Arrieta E, Trujillo H, Folgueira D, Cueto C, Serrano A, Laureiro J, Arévalo-Cañas C, Castillo C, Díaz-Pedroche C, Lumbreras C; INFLUDOC group. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clin Microbiol Infect 2020;26:1557.e9-1557.e15. [PMID: 32120038 DOI: 10.1016/j.cmi.2020.02.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
147 Malainou C, Herold S. [Influenza]. Internist (Berl) 2019;60:1127-35. [PMID: 31478058 DOI: 10.1007/s00108-019-00670-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
148 Kaku N, Kodama H, Akamatsu N, Ota K, Kosai K, Morinaga Y, Narita Y, Matsumoto Y, Matsushita T, Mizuta Y, Izumikawa K, Mukae H, Yanagihara K. Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness. J Infect Chemother 2021;27:820-5. [PMID: 33509674 DOI: 10.1016/j.jiac.2021.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Yoshimura Y, Sasaki H, Horiuchi H, Miyata N, Kawakami C, Usuku S, Tachikawa N. Early combination treatment with baloxavir and peramivir for hospitalized adults with influenza A in Yokohama, Japan. Eur J Clin Microbiol Infect Dis 2020;39:1637-40. [PMID: 32291543 DOI: 10.1007/s10096-020-03888-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Nishi A, Kaifuchi N, Shimobori C, Ohbuchi K, Iizuka S, Sugiyama A, Ogura K, Yamamoto M, Kuroki H, Nabeshima S, Yachie A, Matsuoka Y, Kitano H. Effects of maoto (ma-huang-tang) on host lipid mediator and transcriptome signature in influenza virus infection. Sci Rep 2021;11:4232. [PMID: 33608574 DOI: 10.1038/s41598-021-82707-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Chow EJ, Rolfes MA, O'Halloran A, Anderson EJ, Bennett NM, Billing L, Chai S, Dufort E, Herlihy R, Kim S, Lynfield R, McMullen C, Monroe ML, Schaffner W, Spencer M, Talbot HK, Thomas A, Yousey-Hindes K, Reed C, Garg S. Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study. Ann Intern Med 2020;173:605-13. [PMID: 32833488 DOI: 10.7326/M20-1509] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 10.5] [Reference Citation Analysis]
152 O'Sullivan S, Torres A, Rodriguez A, Martin-Loeches I. Influenza management with new therapies. Curr Opin Pulm Med 2020;26:215-21. [PMID: 32068576 DOI: 10.1097/MCP.0000000000000667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
153 Mombelli M, Kampouri E, Manuel O. Influenza in solid organ transplant recipients: epidemiology, management, and outcomes. Expert Review of Anti-infective Therapy 2020;18:103-12. [DOI: 10.1080/14787210.2020.1713098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
154 Karatas E, Aksoy L, Ozaslan E. Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients. Infect Chemother 2021;53:300-7. [PMID: 34216123 DOI: 10.3947/ic.2020.0149] [Reference Citation Analysis]
155 Shirvani F, Babaie D, Karimi AM. COVID-19 and Influenza: Differences, Similarities, and Coinfection. Arch Pediatr Infect Dis 2022;In Press. [DOI: 10.5812/pedinfect.114358] [Reference Citation Analysis]
156 Ghosh U, Bharathy RVN, Prasad DJH, Moorthy M, Verghese VP. An Eight-Year Profile of Children with Influenza A(H1N1) in a Large Hospital in India. J Trop Pediatr 2021;67:fmab084. [PMID: 34580718 DOI: 10.1093/tropej/fmab084] [Reference Citation Analysis]
157 Leuzinger K, Roloff T, Gosert R, Sogaard K, Naegele K, Rentsch K, Bingisser R, Nickel CH, Pargger H, Bassetti S, Bielicki J, Khanna N, Tschudin Sutter S, Widmer A, Hinic V, Battegay M, Egli A, Hirsch HH. Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis 2020;222:1270-9. [PMID: 32726441 DOI: 10.1093/infdis/jiaa464] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
158 Noël KC, Fontela PS, Winters N, Quach C, Gore G, Robinson J, Dendukuri N, Papenburg J. The Clinical Utility of Respiratory Viral Testing in Hospitalized Children: A Meta-analysis. Hosp Pediatr 2019;9:483-94. [PMID: 31167816 DOI: 10.1542/hpeds.2018-0233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
159 Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200:e45-67. [PMID: 31573350 DOI: 10.1164/rccm.201908-1581ST] [Cited by in Crossref: 772] [Cited by in F6Publishing: 390] [Article Influence: 386.0] [Reference Citation Analysis]
160 Claverias L, Daniel X, Martín-loeches I, Vidal-cortez P, Gómez-bertomeu F, Trefler S, Zaragoza R, Borges-sa M, Reyes L, Quindós G, Peman J, Bodí M, Díaz E, Sarvisé C, Pico E, Papiol E, Solé-violan J, Marín-corral J, Guardiola J, Rodríguez A. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia. Medicina Intensiva 2022. [DOI: 10.1016/j.medin.2021.12.005] [Reference Citation Analysis]
161 Petrie JG, Lauring AS, Martin ET, Kaye KS. Hospital Associated Respiratory Virus Infection in Children and Adults: It Does Not Just Occur During Cold and Flu Season. Open Forum Infect Dis 2020;7:ofaa200. [PMID: 32617374 DOI: 10.1093/ofid/ofaa200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Yokoyama T, Sakaguchi H, Ishibashi T, Shishido T, Piedra PA, Sato C, Tsuchiya K, Uehara T. Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study. Pediatr Infect Dis J 2020;39:706-12. [PMID: 32433222 DOI: 10.1097/INF.0000000000002748] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
163 Obata R, Ernst K. Aphasia and confusion - influenza encephalopathy: atypical presentation of influenza. BMJ Case Rep 2020;13:e235559. [PMID: 33040034 DOI: 10.1136/bcr-2020-235559] [Reference Citation Analysis]
164 Jatlaoui TC, Wiltz JL, Kabbani S, Siegel DA, Koppaka R, Montandon M, Adkins SH, Weissman DN, Koumans EH, O'Hegarty M, O'Sullivan MC, Ritchey MD, Chatham-Stephens K, Kiernan EA, Layer M, Reagan-Steiner S, Legha JK, Shealy K, King BA, Jones CM, Baldwin GT, Rose DA, Delaney LJ, Briss P, Evans ME; Lung Injury Response Clinical Working Group. Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019. MMWR Morb Mortal Wkly Rep 2019;68:1081-6. [PMID: 31751322 DOI: 10.15585/mmwr.mm6846e2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
165 Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, Kakihana Y, Kawasaki T, Kushimoto S, Kuroda Y, Kotani J, Shime N, Taniguchi T, Tsuruta R, Doi K, Doi M, Nakada TA, Nakane M, Fujishima S, Hosokawa N, Masuda Y, Matsushima A, Matsuda N, Yamakawa K, Hara Y, Sakuraya M, Ohshimo S, Aoki Y, Inada M, Umemura Y, Kawai Y, Kondo Y, Saito H, Taito S, Takeda C, Terayama T, Tohira H, Hashimoto H, Hayashida K, Hifumi T, Hirose T, Fukuda T, Fujii T, Miura S, Yasuda H, Abe T, Andoh K, Iida Y, Ishihara T, Ide K, Ito K, Ito Y, Inata Y, Utsunomiya A, Unoki T, Endo K, Ouchi A, Ozaki M, Ono S, Katsura M, Kawaguchi A, Kawamura Y, Kudo D, Kubo K, Kurahashi K, Sakuramoto H, Shimoyama A, Suzuki T, Sekine S, Sekino M, Takahashi N, Takahashi S, Takahashi H, Tagami T, Tajima G, Tatsumi H, Tani M, Tsuchiya A, Tsutsumi Y, Naito T, Nagae M, Nagasawa I, Nakamura K, Nishimura T, Nunomiya S, Norisue Y, Hashimoto S, Hasegawa D, Hatakeyama J, Hara N, Higashibeppu N, Furushima N, Furusono H, Matsuishi Y, Matsuyama T, Minematsu Y, Miyashita R, Miyatake Y, Moriyasu M, Yamada T, Yamada H, Yamamoto R, Yoshida T, Yoshida Y, Yoshimura J, Yotsumoto R, Yonekura H, Wada T, Watanabe E, Aoki M, Asai H, Abe T, Igarashi Y, Iguchi N, Ishikawa M, Ishimaru G, Isokawa S, Itakura R, Imahase H, Imura H, Irinoda T, Uehara K, Ushio N, Umegaki T, Egawa Y, Enomoto Y, Ota K, Ohchi Y, Ohno T, Ohbe H, Oka K, Okada N, Okada Y, Okano H, Okamoto J, Okuda H, Ogura T, Onodera Y, Oyama Y, Kainuma M, Kako E, Kashiura M, Kato H, Kanaya A, Kaneko T, Kanehata K, Kano KI, Kawano H, Kikutani K, Kikuchi H, Kido T, Kimura S, Koami H, Kobashi D, Saiki I, Sakai M, Sakamoto A, Sato T, Shiga Y, Shimoto M, Shimoyama S, Shoko T, Sugawara Y, Sugita A, Suzuki S, Suzuki Y, Suhara T, Sonota K, Takauji S, Takashima K, Takahashi S, Takahashi Y, Takeshita J, Tanaka Y, Tampo A, Tsunoyama T, Tetsuhara K, Tokunaga K, Tomioka Y, Tomita K, Tominaga N, Toyosaki M, Toyoda Y, Naito H, Nagata I, Nagato T, Nakamura Y, Nakamori Y, Nahara I, Naraba H, Narita C, Nishioka N, Nishimura T, Nishiyama K, Nomura T, Haga T, Hagiwara Y, Hashimoto K, Hatachi T, Hamasaki T, Hayashi T, Hayashi M, Hayamizu A, Haraguchi G, Hirano Y, Fujii R, Fujita M, Fujimura N, Funakoshi H, Horiguchi M, Maki J, Masunaga N, Matsumura Y, Mayumi T, Minami K, Miyazaki Y, Miyamoto K, Murata T, Yanai M, Yano T, Yamada K, Yamada N, Yamamoto T, Yoshihiro S, Tanaka H, Nishida O. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg 2021;8:e659. [PMID: 34484801 DOI: 10.1002/ams2.659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Xie Z. Pay attention to SARS-CoV-2 infection in children. Pediatr Investig 2020;4:1-4. [PMID: 32851334 DOI: 10.1002/ped4.12178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
167 Koehler P, Bassetti M, Kochanek M, Shimabukuro-vornhagen A, Cornely O. Intensive care management of influenza-associated pulmonary aspergillosis. Clinical Microbiology and Infection 2019;25:1501-9. [DOI: 10.1016/j.cmi.2019.04.031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
168 Lewandowski K, Xu Y, Pullan ST, Lumley SF, Foster D, Sanderson N, Vaughan A, Morgan M, Bright N, Kavanagh J, Vipond R, Carroll M, Marriott AC, Gooch KE, Andersson M, Jeffery K, Peto TEA, Crook DW, Walker AS, Matthews PC. Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory Samples. J Clin Microbiol 2019;58:e00963-19. [PMID: 31666364 DOI: 10.1128/JCM.00963-19] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 17.3] [Reference Citation Analysis]
169 Petrie JG, Talbot TR. Health Care-Acquired Viral Respiratory Diseases. Infect Dis Clin North Am 2021;35:1055-75. [PMID: 34752220 DOI: 10.1016/j.idc.2021.07.007] [Reference Citation Analysis]
170 Zaraket H, Hurt AC, Clinch B, Barr I, Lee N. Burden of influenza B virus infection and considerations for clinical management. Antiviral Res 2021;185:104970. [PMID: 33159999 DOI: 10.1016/j.antiviral.2020.104970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Hanson KE, Azar MM, Banerjee R, Chou A, Colgrove RC, Ginocchio CC, Hayden MK, Holodiny M, Jain S, Koo S, Levy J, Timbrook TT, Caliendo AM. Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee. Clin Infect Dis 2020;71:2744-51. [PMID: 32369578 DOI: 10.1093/cid/ciaa508] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
172 [DOI: 10.1101/2020.03.19.20039180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
173 Choi M, Lee SH, Chang GT. Herbal Medicine Treatment for Influenza: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Chin Med 2020;48:1553-76. [PMID: 33167671 DOI: 10.1142/S0192415X20500779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Song X, Delaney M, Shah RK, Campos JM, Wessel DL, DeBiasi RL. Common seasonal respiratory viral infections in children before and during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2021;:1-5. [PMID: 34607617 DOI: 10.1017/ice.2021.430] [Reference Citation Analysis]
175 Falavigna M, Colpani V, Stein C, Azevedo LCP, Bagattini AM, Brito GV, Chatkin JM, Cimerman S, Corradi MFDB, Cunha CAD, Medeiros FC, Oliveira Junior HA, Fritscher LG, Gazzana MB, Gräf DD, Marra LP, Matuoka JY, Nunes MS, Pachito DV, Pagano CGM, Parreira PCS, Riera R, Silva A Júnior, Tavares BM, Zavascki AP, Rosa RG, Dal-Pizzol F. Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology. Rev Bras Ter Intensiva 2020;32:166-96. [PMID: 32667444 DOI: 10.5935/0103-507x.20200039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
176 Chow EJ, Doyle JD, Uyeki TM. Influenza virus-related critical illness: prevention, diagnosis, treatment. Crit Care 2019;23:214. [PMID: 31189475 DOI: 10.1186/s13054-019-2491-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]
177 Akashi Y, Suzuki H, Ueda A, Hirose Y, Hayashi D, Imai H, Ishikawa H. Analytical and clinical evaluation of a point-of-care molecular diagnostic system and its influenza A/B assay for rapid molecular detection of the influenza virus. J Infect Chemother 2019;25:578-83. [PMID: 30905631 DOI: 10.1016/j.jiac.2019.02.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
178 Nuñez-Conde A, Marquez-Algaba E, Falcó V, Almirante B, Burgos J. Organizing pneumonia secondary to influenza infection: Two case reports and a literature review. Enferm Infecc Microbiol Clin (Engl Ed) 2020;38:123-6. [PMID: 31126691 DOI: 10.1016/j.eimc.2019.04.006] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
179 Zwillenberg M, Tang E, Quaas J. Neuraminidase inhibitors for treatment of influenza. Acad Emerg Med 2021;28:1195-7. [PMID: 33635574 DOI: 10.1111/acem.14241] [Reference Citation Analysis]
180 Vos LM, Oosterheert JJ, Hoepelman AIM, Bont LJ, Coenjaerts FEJ, Naaktgeboren CA. External validation and update of a prognostic model to predict mortality in hospitalized adults with RSV: A retrospective Dutch cohort study. J Med Virol 2019;91:2117-24. [PMID: 31410862 DOI: 10.1002/jmv.25568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
181 Nebreda-Mayoral T, Miguel-Gómez MA, March-Rosselló GA, Puente-Fuertes L, Cantón-Benito E, Martínez-García AM, Muñoz-Martín AB, Orduña-Domingo A. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain. Enferm Infecc Microbiol Clin (Engl Ed) 2020:S0213-005X(20)30404-3. [PMID: 33413990 DOI: 10.1016/j.eimc.2020.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
182 Esden J. Treatment update: Outpatient management of community-acquired pneumonia. Nurse Pract 2020;45:16-25. [PMID: 32015283 DOI: 10.1097/01.NPR.0000653944.99226.25] [Reference Citation Analysis]
183 Losier A, Dela Cruz CS. New testing guidelines for community-acquired pneumonia. Curr Opin Infect Dis 2022;35:128-32. [PMID: 35245248 DOI: 10.1097/QCO.0000000000000824] [Reference Citation Analysis]
184 Al-Zayadneh E, Mohammad Abu Assab D, Adeeb Arabiat E, Al-Iede M, Ahmad Kayed H, Daher A. The burden of influenza and other respiratory viruses in hospitalized infants and children in a university hospital, Jordan. Multidiscip Respir Med 2021;16:763. [PMID: 34900252 DOI: 10.4081/mrm.2021.763] [Reference Citation Analysis]
185 Silva JB, Bosco E, Quilliam DN, Gravenstein S, Zullo AR. Antiviral Chemoprophylaxis Use During Influenza Outbreaks in Rhode Island Long-Term Care Facilities. J Am Med Dir Assoc 2020;21:1354-6. [PMID: 32660853 DOI: 10.1016/j.jamda.2020.05.020] [Reference Citation Analysis]
186 Anania VG, Randolph AG, Yang X, Nguyen A, Newhams MM, Mathews WR, Rosenberger CM, McBride JM. Early Amplified Respiratory Bioactive Lipid Response Is Associated With Worse Outcomes in Pediatric Influenza-Related Respiratory Failure. Open Forum Infect Dis 2020;7:ofaa122. [PMID: 32420403 DOI: 10.1093/ofid/ofaa122] [Reference Citation Analysis]
187 Wang A, Gao G, Wang S, Chen M, Qian F, Tang W, Xu Y, Song R, Zhuang L, Ma X, Zhao T, Guo X, Li W, Wang X, Li B, Hu C, Chen Z, Zhang F. Clinical Characteristics and Risk Factors of Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients in Beijing, China: A Retrospective Study. Med Sci Monit. 2020;26:e925974. [PMID: 32973126 DOI: 10.12659/msm.925974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
188 Mitamura K, Yamazaki M, Ichikawa M, Yasumi Y, Shiozaki K, Tokushima M, Abe T, Kawakami C. Clinical usefulness of a rapid molecular assay, ID NOW™ influenza A & B 2, in adults. J Infect Chemother 2021;27:450-4. [PMID: 33218876 DOI: 10.1016/j.jiac.2020.10.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Iwasaki T, Hifumi T, Hayashi K, Otani N, Ishimatsu S. Rapid influenza diagnostic test at triage can decrease emergency department length of stay. J Am Coll Emerg Physicians Open 2020;1:494-501. [PMID: 33000076 DOI: 10.1002/emp2.12125] [Reference Citation Analysis]
190 Sharma Y, Horwood C, Hakendorf P, Thompson C. Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients. Int J Infect Dis 2021;104:232-8. [PMID: 33434667 DOI: 10.1016/j.ijid.2021.01.011] [Reference Citation Analysis]
191 Robinson CP, Busl KM. Neurologic Manifestations of Severe Respiratory Viral Contagions. Crit Care Explor 2020;2:e0107. [PMID: 32426749 DOI: 10.1097/CCE.0000000000000107] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
192 Loubet P, Mathieu P, Lenzi N, Galtier F, Lainé F, Lesieur Z, Vanhems P, Duval X, Postil D, Amour S, Rogez S, Lagathu G, L'Honneur AS, Foulongne V, Houhou N, Lina B, Carrat F, Launay O; Fluvac study group. Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012-2018: a retrospective observational study. Clin Microbiol Infect 2021;27:127.e1-6. [PMID: 32283266 DOI: 10.1016/j.cmi.2020.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
193 Doron S, Horowitz G. Medical Appropriateness and Economics of Nucleic Acid Amplification Testing for Infectious Diseases. Clin Biochem 2022:S0009-9120(22)00116-3. [PMID: 35489474 DOI: 10.1016/j.clinbiochem.2022.04.013] [Reference Citation Analysis]
194 Wabe N, Li L, Lindeman R, Post JJ, Dahm MR, Li J, Westbrook JI, Georgiou A. Evaluation of the accuracy of diagnostic coding for influenza compared to laboratory results: the availability of test results before hospital discharge facilitates improved coding accuracy. BMC Med Inform Decis Mak 2021;21:168. [PMID: 34022851 DOI: 10.1186/s12911-021-01531-9] [Reference Citation Analysis]
195 Watson A, Wilkinson TMA. Respiratory viral infections in the elderly. Ther Adv Respir Dis 2021;15:1753466621995050. [PMID: 33749408 DOI: 10.1177/1753466621995050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
196 Wu L, Chen Y, Ma Y, Yang Z, Yang N, Deng W, Chen Y, Sun Y, Li Y, Lin L. Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines. Pharmacol Res 2020;160:105101. [PMID: 32739428 DOI: 10.1016/j.phrs.2020.105101] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
197 Lee N, Smith SW, Hui DSC, Ye M, Zelyas N, Chan PKS, Drews SJ, Zapernick L, Wong R, Labib M, Shokoples S, Eurich DT. Development of an Ordinal Scale Treatment Endpoint for Adults Hospitalized With Influenza. Clin Infect Dis 2020:ciaa777. [PMID: 32827251 DOI: 10.1093/cid/ciaa777] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Katsuki M, Matsuo M. Relationship Between Medical Questionnaire and Influenza Rapid Test Positivity: Subjective Pretest Probability, "I Think I Have Influenza," Contributes to the Positivity Rate. Cureus 2021;13:e16679. [PMID: 34462700 DOI: 10.7759/cureus.16679] [Reference Citation Analysis]